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Introduction
Post streptococcal disease caused by beta hemolytic 
streptococcus group A comprise joint involvement, 
acute renal failure, abnormal involuntary movements, 
and cardiac involvement 1,2 . Joint pain can be divided 
into two distinct presentations: acute rheumatic fever 
whose peak age is 5-15 years 3,4 and which  can be  a 
potential source of  complications such as heart diseases 
5 ; and post streptococcal arthritis 6,7 .
The prevalence of  post streptococcal diseases 
considerably decreased in industrialized countries but 
it still remains a major public health concern among 
developing countries 8,9 . Immunological testing is 
necessary in order to prove that clinical symptoms are 
caused by  post streptococcal diseases: by performing
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two antibodies tests such as antistreptolysin O (ASO) 
and antistreptodornase B which are directed against 
extracellular antigen of  streptococcus of  group A10.  
Only the titration of  ASO is currently available in labs 
within any public health centers in Madagascar. This 
study aimed to describe the current practice of  these 
requests in Antananarivo.
Methods
We conducted a retrospective and descriptive study 
during a period of  seven years from January 2003 to 
December 2009, at the Para clinic unit of  Immunology 
at the University Center Hospital Joseph Ravoahangy 
Andrianavalona, Antananarivo, Madagascar.
All requests from both inpatients and outpatients of  
ASO were included in this study, and we excluded 
incomplete data, especially those in which the age was 
missing. The variables which were recorded for each 
individual request were the age of  the patient, the gender, 
the clinical symptom mentioned by the physician for 
the request of  ASO titration and the ASO titre value 
of  each request. As there was no epidemiological study 
done in order to determine the normal valoe of  ASO 
titer in Madagascar, we retained as significant all ASO 
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titre values more than 200 U/ml  6. Three milliliters of  
blood was obtained by venipuncture of  the forearm, and 
then it was centrifuged with 1500g during 10 minutes. 
As the test was made once a week, the serum was stored 
at +4°C until the test was made. The titration of  ASO 
level was performed with a latex agglutination technique 
(Humatex ASLO ® (Human GmBh)) according to the 
manufacturer instructions. 50 microliters of  serum was 
mixed with one drop of  the latex reagent, and then it 
was shaken with a Kline shaker with 100 rpm during 2 
minutes before reading it.
We used Epi info software version3.5.1 (CDC Atlanta) 
for the statistical analysis.
Results
There were 4149 requests of  ASO titration during the 
whole period of  study and we retained 4143 of  them. 
Table I: Frequency of  symptoms leading to a request of  ASO  





Others (1) 84 2.03%
Neurologic Chorea 28 0.68%
(13,90%) Seizure 103 2.49%
 Others (2) 440 10.62%
Heart diseases Cardiomyopathy(3) 53 1.28%
(8,50%) Valvulopathy(4) 165 3.98%
 Endocarditis 43 1.04%
 Others(5) 91 2.20%
Nephrology Acute renal failure 7 0.17%
(3,20%) Glomerulonephritis 5 0.12%
 Others (6) 30 0.72%
Oto Rhino Laryngology Tonsillitis 94 2.27%
(2,40%) Others(7) 5 0.12%
Dermatology Nodula 4 0.10%
(1,30%) Erythema 16 0.39%
 Others(8) 35 0.84%
Edema (9) 89 2.15%
(2.15%)
Others (10)  817 19.72%
(19,72%)
No clinical information  428 10.33%
(10 ,33%)
TOTAL  4143 100.00%
 : Bone pain , backpain, functional disability(1) 
 : Headache, stroke, hemiplegia , (2) 
 : ischemic, hypertrophic, dilated or restrictive cardiomyopathy(3) 
: all heart valves sounds abnormalities confirmed or not by echography(4) 
arterial hypertension, pericarditis, heart angina, (5) 
 : dysuria, urinary infection  (6) 
 : keratitis, otitis , keratoconjonctivitis(7) 
 : cutaneous eruption, furunculus, eczema(8) 
 : all causes of  edema (9) 
 : vertigo, tuberculosis, chickenpox, behavioral disorder, stiff  neck(10) 
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The mean age was 32.9 years (ranging from 01 to 89 years), with a female predominance (62.3%). Only 18.3% of  
all requests came from children under 15 years of  age (fig 1).
Figure 1: Frequency of  ASO prescription depending on age
Rheumatologic, neurologic and heart diseases were the 
most frequent causes of  request. For the rheumatologic 
symptoms, arthralgia (35.6%) and arthritis (3.2%) were 
the most frequent. For the neurological symptoms, 
chorea (4.91%) was the most frequent and for heart 
diseases, valvulopathy (46.87%) was the most frequent. 
Almost 10.3% of  all requests (4,143) did not contain any 
clinical information. For 19.72 % of  requests (4,143), 
the main symptom which led to an ASO titration did 
not correlate with any disease related to streptococcal 
infection, such as Burkitt lymphoma, dizziness, Grave’s 
disease, delirium tremens, acute leukemia, limp etc. 
The figure 2 shows the ASO tire levels of  all requests. 
Only 15% of  the request had significant ASO titres, 
with those with “borderline normal” (ASO titre = 200 
U/ml) being 23%.
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Figure 2: ASO titre levels
  The figure 3 shows the distribution of  ASO titre levels 
depending on the type of  symptoms. No abnormal 
ASO titre value was found for gynecological symptoms 
and tor the others, these abnormal values ranged from 
10.96% for neurological symptoms to 21.82% for 
dermatological symptoms. Borderline normal values 
ranged from 17.56% for nephrological symptoms to 
40% for gynecological symptoms.
Figure 3: ASO titre and symptoms
Discussion
The prevalence of  streptococcal infections remains very 
high in Madagascar and the severity of  its complications 
reinforces the need of  a precise diagnosis, mainly an 
immunological proof  of  the infection. The two most 
prescribed analyses are ASO and antistreptodornase 11, 
especially when auto immune complications occurred, 
such as rheumatic fever or a post streptococcal 
glomerulonephritis. Some guidelines are now available 
especially for rheumatologic symptoms 3,5,12.  The main 
finding in our study is that most of  ASO requests showed 
a low level of  ASO titre, despite the level of  endemicity 
of  streptococcal infection in Antananarivo. Moreover, 
even if  the level of  ASO titer is high, it doesn’t mean 
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necessarily that the patient has a true post streptococcal 
infection because the antibodies titre decrease slowly 
and may persist longtime after the infection 13. Besides, 
a single ASO titre assay has some limitations, especially 
with regard to chronic nasopharyngeal group A beta 
hemolytic streptococcus carriage status. The majority 
of  the patients having joint complaints who went to 
our labs were aged of  20 to 30 years, which is not 
compatible with the typical presentation of  acute 
rheumatic fever usually occurring in children aged of  
5 yrs. to 14 yrs. 14 .  The first hypothesis which can 
explain this fact is that our physicians did not have 
appropriate and updated knowledge about ASO request 
that’s why they prescribed it as a routine analysis. The 
second hypothesis is that they are thinking about the 
post streptococcal arthritis instead of  others causes of  
arthralgia in adults 15. The evaluation of  ASO titer is a 
part of  the current guidelines for the diagnosis of  acute 
rheumatic fever 16. There is an increase of  the ASO titer 
one week after the infection with a maximal level in 3 
weeks, and the level of  antistreptodornase reaches its 
maximal level in 6 weeks 17. It’s suggested that both of  
them must be evaluated 18. The physician also needs to 
put a strong emphasis on the seroconversion which is 
more important than a high level of  antibodies found 
alone 13. 
Chorea is one of  the symptoms which may justify a 
request of  ASO titer 19 and it occurs mainly among 
young women during teenage 20. 
For heart diseases, it is known that they are part of  
the most severe complications of  post streptococcal 
diseases in developing countries, and they are part of  
prognostic criteria for the issue of  the disease 21.
The ASO titer is useful to diagnose a post streptococcal 
glomerulonephritis, in addition to a renal biopsy, but 
they are rare among adults 22. Moreover, ASO titer may 
be under than 200 U/ml in adults aged more than 60 
yrs 23. So, only 2.4% of  our requests are justified in case 
of  renal symptoms.
About dermatological symptoms, they may be due to 
the streptococcus, such as impetigo of  cellulitis, or due 
to post streptococcal diseases, such as emarginated 
erythema or Meynet’s nodule 20. So, only 0.5% of  our 
demands were relevant.
Recurrent tonsillitis may be due to bacteria or viruses, 
and some authors recommend an evaluation of  ASO 
titer to distinguish both of  them 24; it is also the case 
for pharyngitis in infants 25. But it is better to perform a 
bacteriological diagnosis to find the presence or not of  
streptococci because the other sites of  streptococci may 
increase the ASO titer level leading to a misdiagnosis of  
an infection.
For 19.72% of  our demands, the requests were not 
relevant (for example, a request for ASO titration is not 
relevant in stiff  neck or in chickenpox), and it is essential 
to encourage physicians to update their knowledge by 
searching data through the Internet for example.
There are some limitations in our study. Until now, 
there was no study which aimed to determine the 
cut off  for ASO level among the population living in 
Antananarivo, so we retained as significant level a titer 
of  ASO more than 200 U/ml. Indeed, the ASO level 
may vary depending age groups of  patients, site of  
streptococcal infection and different seasons, and on 
each country 15,26,27  and we think that it may be one of  
the research topics here in Antananarivo. 
Finally, group A streptococci are part of  normal flora in 
the nasopharynx and the test must be repeated in case 
of  high level in order to show the increase of  the titre 
in a case of  a true infection. Nonetheless, it is not often 
feasible to obtain acute and convalescent sera, hence 
the use of  a single cut off  level.
Conclusion
We found that the majority of  ASO requests don’t 
show a significant level in Antananarivo. We think that 
maybe the baseline level of  ASO is lower than 200 U/l 
so the next step is to perform a study among general 
population in order to determine the normal value of  
this parameter.
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